Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,692,720
+$637,035 QoQ
Shares Held
2,245
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#2,231
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Westside Investment Management, Inc. holds $16,730,523 across 16 Drug Manufacturers - General names. LLY ranks #4 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
16,600 | $4,177,223 | |
| 2 | AMGN |
Amgen Inc
|
9,816 | $3,554,569 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
22,902 | $2,893,438 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,245 | $2,692,720 | |
| 5 | JNJ |
Johnson & Johnson
|
4,698 | $1,193,149 | |
| 6 | BIIB |
Biogen Inc.
|
2,634 | $569,101 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,884 | $396,655 | |
| 8 | PFE |
Pfizer Inc
|
16,318 | $392,937 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,692,720 | 2,245 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,055,685 | 2,235 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,461,017 | 2,290 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,768,634 | 2,318 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,652,603 | 2,120 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,625,390 | 1,968 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,515,436 | 1,963 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,832,123 | 2,068 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $2,053,401 | 2,268 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,770,636 | 2,276 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,327,891 | 2,278 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,329,933 | 2,476 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,237,169 | 2,638 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $905,941 | 2,638 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $998,011 | 2,728 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $895,032 | 2,768 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $856,939 | 2,643 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $756,875 | 2,643 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $151,921 | 550 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $127,077 | 550 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $126,236 | 550 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $102,751 | 550 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $88,641 | 525 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $82,891 | 560 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $91,940 | 560 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $97,104 | 700 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||